Page last updated: 2024-11-04

sulforaphane and Metabolic Diseases

sulforaphane has been researched along with Metabolic Diseases in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research Excerpts

ExcerptRelevanceReference
" To allow comparison between rodent and human studies, we discuss the published bioavailability of SFN metabolites achieved in rodents and man in the context of Nrf2, NFκB and PPARγ signaling."2.58Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome. ( Chapple, SJ; Mann, GE; Patel, B, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patel, B1
Mann, GE1
Chapple, SJ1

Reviews

1 review available for sulforaphane and Metabolic Diseases

ArticleYear
Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome.
    Free radical biology & medicine, 2018, Volume: 122

    Topics: Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Isothiocyanates; Metabolic

2018